{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:28:10Z","timestamp":1790483290562,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10549-017-4283-8","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T17:28:33Z","timestamp":1494523713000},"page":"527-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Critical appraisal of health-state utility values used in breast cancer-related cost\u2013utility analyses"],"prefix":"10.1007","volume":"164","author":[{"given":"Virginie","family":"Nerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopany","family":"Saing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Gamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Holzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pivot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Viney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"key":"4283_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2217\/fon.12.61","volume":"8","author":"JR Benson","year":"2012","unstructured":"Benson JR, Jatoi I (2012) The global breast cancer burden. Future Oncol 8:697\u2013702. doi: 10.2217\/fon.12.61","journal-title":"Future Oncol"},{"key":"4283_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.amepre.2015.08.009","volume":"50","author":"AN Winn","year":"2016","unstructured":"Winn AN, Ekwueme DU, Guy GP, Neumann PJ (2016) Cost\u2013utility analysis of cancer prevention, treatment, and control: a systematic review. Am J Prev Med 50:241\u2013248. doi: 10.1016\/j.amepre.2015.08.009","journal-title":"Am J Prev Med"},{"key":"4283_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10549-016-3924-7","volume":"159","author":"V Nerich","year":"2016","unstructured":"Nerich V, Saing S, Gamper M et al (2016) Cost\u2013utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Res Treat 159:407\u2013424. doi: 10.1007\/s10549-016-3924-7","journal-title":"Breast Cancer Res Treat"},{"key":"4283_CR4","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programmes","author":"M Drummond","year":"2005","unstructured":"Drummond M, Sculpher M, O\u2019Brien B (2005) Methods for the economic evaluation of health care programmes. Oxford University Press, Torrance"},{"key":"4283_CR5","first-page":"118","volume":"7","author":"GW Torrance","year":"1972","unstructured":"Torrance GW, Thomas WH, Sackett DL (1972) A utility maximization model for evaluation of health care programs. Health Serv Res 7:118\u2013133","journal-title":"Health Serv Res"},{"key":"4283_CR6","volume-title":"Theory of games and economic behavior (60th Anniversary Commemorative Edition) (eBook and Paperback)","author":"J Neumann von","year":"1947","unstructured":"von Neumann J, Morgenstern O (1947) Theory of games and economic behavior (60th Anniversary Commemorative Edition) (eBook and Paperback), 2nd edn. Princeton University Press, London","edition":"2"},{"key":"4283_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0038-0121(76)90036-7","volume":"10","author":"GW Torrance","year":"1976","unstructured":"Torrance GW (1976) Social preferences for health states: an empirical evaluation of three measurement techniques. Socioecon Plann Sci 10:129\u2013136","journal-title":"Socioecon Plann Sci"},{"key":"4283_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R (1996) EuroQol: the current state of play. Health Policy 37:53\u201372","journal-title":"Health Policy"},{"key":"4283_CR9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727\u20131736. doi: 10.1007\/s11136-011-9903-x","journal-title":"Qual Life Res"},{"key":"4283_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00019053-199507060-00005","volume":"7","author":"GW Torrance","year":"1995","unstructured":"Torrance GW, Furlong W, Feeny D, Boyle M (1995) Multi-attribute preference functions: health Utilities Index. PharmacoEconomics 7:503\u2013520","journal-title":"PharmacoEconomics"},{"key":"4283_CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00005650-199607000-00004","volume":"34","author":"GW Torrance","year":"1996","unstructured":"Torrance GW, Feeny DH, Furlong WJ et al (1996) Multiattribute utility function for a comprehensive health status classification system. Health utilities index mark 2. Med Care 34:702\u2013722","journal-title":"Med Care"},{"key":"4283_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271\u2013292","journal-title":"J Health Econ"},{"key":"4283_CR13","unstructured":"Decision Support Unit. Technical Support Document 9: The identification, review, and synthesis of health state utility values from the literature"},{"key":"4283_CR14","unstructured":"The National Institute for Health and Care Excellence (NICE) Guide to the methods of technology appraisal 2013: guidance and guidelines. https:\/\/www.nice.org.uk\/article\/pmg9\/chapter\/Foreword . Accessed 3 Mar 2017"},{"key":"4283_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","volume":"16","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S et al (2013) Consolidated health economic evaluation reporting standards (CHEERS)\u2013explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health 16:231\u2013250. doi: 10.1016\/j.jval.2013.02.002","journal-title":"Value Health"},{"key":"4283_CR16","doi-asserted-by":"publisher","first-page":"e1000217","DOI":"10.1007\/BF03022653","volume":"7","author":"D Moher","year":"2010","unstructured":"Moher D, Schulz KF, Simera I, Altman DG (2010) Guidance for developers of health research reporting guidelines. PLoS Med 7:e1000217. doi: 10.1007\/BF03022653","journal-title":"PLoS Med"},{"key":"4283_CR17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1517\/14656566.6.11.1789","volume":"6","author":"A Benedict","year":"2005","unstructured":"Benedict A, Brown RE (2005) Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer. Expert Opin Pharmacother 6:1789\u20131801","journal-title":"Expert Opin Pharmacother"},{"key":"4283_CR18","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/S0140-6736(11)61256-7","volume":"378","author":"M Calvert","year":"2011","unstructured":"Calvert M, Blazeby J, Revicki D et al (2011) Reporting quality of life in clinical trials: a CONSORT extension. Lancet 378:1684\u20131685. doi: 10.1016\/S0140-6736(11)61256-7","journal-title":"Lancet"},{"key":"4283_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","volume":"309","author":"M Calvert","year":"2013","unstructured":"Calvert M, Blazeby J, Altman DG et al (2013) Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 309:814\u2013822. doi: 10.1001\/jama.2013.879","journal-title":"JAMA"},{"key":"4283_CR20","unstructured":"International Society For Pharmacoeconomics and Outcomes Research (ISPOR) Measurement of health state utility values for economic models in clinical studies. http:\/\/www.ispor.org\/taskforces\/health-utility-values-in-clinical-studies-grp.asp . Accessed 3 Mar 2017"},{"key":"4283_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/erp.10.65","volume":"10","author":"T Peasgood","year":"2010","unstructured":"Peasgood T, Ward SE, Brazier J (2010) Health-state utility values in breast cancer. Expert Rev Pharmacoecon Outcomes Res 10:553\u2013566. doi: 10.1586\/erp.10.65","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4283_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jval.2015.11.003","volume":"19","author":"M Herdman","year":"2016","unstructured":"Herdman M, Cole A, Hoyle CK et al (2016) Sources and characteristics of utility weights for economic evaluation of pediatric vaccines: a systematic review. Value Health 19:255\u2013266. doi: 10.1016\/j.jval.2015.11.003","journal-title":"Value Health"},{"key":"4283_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10198-013-0459-2","volume":"15","author":"B Parkinson","year":"2014","unstructured":"Parkinson B, Pearson S-A, Viney R (2014) Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique. Eur J Health Econ 15:93\u2013112. doi: 10.1007\/s10198-013-0459-2","journal-title":"Eur J Health Econ"},{"key":"4283_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jval.2010.10.015","volume":"14","author":"JC Tosh","year":"2011","unstructured":"Tosh JC, Longworth LJ, George E (2011) Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals. Value Health 14:102\u2013109. doi: 10.1016\/j.jval.2010.10.015","journal-title":"Value Health"},{"key":"4283_CR25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00019053-200826040-00003","volume":"26","author":"PA Scuffham","year":"2008","unstructured":"Scuffham PA, Whitty JA, Mitchell A, Viney R (2008) The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme\u00a02002\u20132004. PharmacoEconomics 26:297\u2013310","journal-title":"PharmacoEconomics"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4283-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4283-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4283-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T02:15:46Z","timestamp":1719195346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4283-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4283"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4283-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}